Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Natasha on +44 1494 818 053 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Natasha Wilson
Executive Recruiter
+44 1494 818 053

Zenopa are extremely personable and a pleasure to work with. They did a great job at liaising with potential employers and kept me updated at all times.
Steve, 2014

Novo Nordisk launches FlexTouch insulin pen

11 October 2011 00:00 in Pharmaceutical Company Product News

Novo Nordisk has introduced its new disposable prefilled insulin pen device FlexTouch in the UK.

The new product is designed for use with the company's rapid-acting modern insulin analogue NovoRapid and allows insulin to be administered at any dose, from 1 to 80 units, via a single button press.

A spring incorporated into its unique design means the device itself is able to absorb the force of the injection, making it extremely easy to use, while also setting apart from other products of the same type.

Novo Nordisk is making the FlexTouch pen available in order to provide a new therapy option that will help diabetes patients to manage their condition with as little disruption to their lives as possible.

Viggo Birch, managing director for Novo Nordisk, said: "Novo Nordisk is committed to continually improving our diabetes medicines and devices that can help solve some of the major challenges people with diabetes face every day."

Last month, the company published new clinical trial data for its new diabetes therapy insulin degludec, showing the glycaemic control benefits the treatment can offer.ADNFCR-8000103-ID-800754520-ADNFCR

Other news stories from 11/10/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd